XML 97 R85.htm IDEA: XBRL DOCUMENT v3.25.1
LEGAL PROCEEDINGS - Intellectual Property (Details)
1 Months Ended 3 Months Ended
Apr. 04, 2025
Mar. 28, 2025
Mar. 26, 2025
Feb. 05, 2025
Nov. 07, 2024
Nov. 01, 2024
Sep. 27, 2024
Apr. 05, 2024
Sep. 10, 2021
Feb. 17, 2020
Mar. 31, 2021
defendant
proceeding
Mar. 31, 2025
proceeding
Norwich I Xifaxan Litigation                        
Loss Contingencies [Line Items]                        
Stay of the approval, period                   30 months    
Amneal Xifaxan Litigation                        
Loss Contingencies [Line Items]                        
Stay of approval, period               30 months        
Zydus Xifaxan Litigation                        
Loss Contingencies [Line Items]                        
Stay of approval, period             30 months          
Cipla Anticipated Xifaxan Litigation                        
Loss Contingencies [Line Items]                        
Stay of the approval, period           30 months            
Carnegie Anticipated Xifaxan Litigation                        
Loss Contingencies [Line Items]                        
Stay of the approval, period         30 months              
Mylan Anticipated Xifaxan Litigation                        
Loss Contingencies [Line Items]                        
Stay of the approval, period     30 months                  
SABA Anticipated Xifaxan Litigation | Subsequent Event                        
Loss Contingencies [Line Items]                        
Stay of the approval, period 30 months                      
The Anticipated Cabtreo Paragraph IV Proceedings                        
Loss Contingencies [Line Items]                        
Stay of the approval, period       30 months                
PreserVision® AREDS Patent Litigation | Pending Litigation | Bausch + Lomb                        
Loss Contingencies [Line Items]                        
Number of defendants | defendant                     20  
Number of proceedings                     17  
PreserVision® AREDS Patent Litigation | Settled Litigation | Bausch + Lomb                        
Loss Contingencies [Line Items]                        
Number of defendants                       15
PreserVision® AREDS Patent Litigation | Default Judgement | Bausch + Lomb                        
Loss Contingencies [Line Items]                        
Number of defendants                       2
Lumify Paragraph I V Proceedings Slayback ANDA Litigation | Bausch + Lomb                        
Loss Contingencies [Line Items]                        
Stay of the approval, period                 30 months      
Lumify Paragraph I V Proceedings Somerset ANDA Litigation | Bausch + Lomb                        
Loss Contingencies [Line Items]                        
Stay of the approval, period   30 months                    
Lumify Paragraph I V Proceedings Gland ANDA Litigation | Bausch + Lomb                        
Loss Contingencies [Line Items]                        
Stay of the approval, period   30 months